相关实验视频
Updated: Jul 16, 2025

13:10
DNA Vector-based RNA Interference to Study Gene Function in Cancer
Published on: June 4, 2012
20.6K
通过病毒载体进行RNA干扰的最佳传递,用于癌症治疗
Boaz Wong1, Rayanna Birtch1, Reza Rezaei1
1Centre for Innovative Cancer Research, Ottawa Hospital Research Institute, Ottawa, ON K1H 8L6, Canada; Department of Biochemistry, Microbiology and Immunology, Faculty of Medicine, University of Ottawa, Ottawa, ON K1H 8M5, Canada.
Molecular therapy : the journal of the American Society of Gene Therapy
|September 22, 2023
概括
病毒载体正在推进对疾病的RNA干扰 (RNAi) 疗法. 本综述探讨了它们在癌症治疗中的潜力,强调了成功的挑战和策略.
科学领域:
- 生物技术是生物技术.
- 基因治疗 基因治疗
- 在瘤学瘤学.
背景情况:
- 病毒载体在工程,交付和安全方面经历了重大创新.
- 这些进步使病毒载体成为RNA干扰 (RNAi) 传递的有力工具.
- 虽然在治疗其他疾病方面取得了成功,但它们在癌症治疗中的应用在很大程度上仍未得到开发.
研究的目的:
- 审查新兴的RNAi治疗的病毒载体传递系统.
- 讨论将这些系统应用于癌症治疗的局限性和挑战.
- 为推动基于病毒载体的RNAi癌症治疗提供有关导航挑战的见解.
主要方法:
- 对用于基因传递的病毒载体平台的当前文献的综述.
- 对抗癌症效应的RNAi点的分析.
- 检查提高RNAi疗法的安全性和有效性的策略.
主要成果:
- 确定有前途的集成和非集成病毒平台.
- 目前针对抗癌应用的RNAi目标的概述.
- 讨论病毒载体介导RNAi的优化策略.
结论:
- 病毒载体对基于RNAi的癌症治疗有显著的前景.
- 克服交付,安全性和疗效方面的挑战对于临床翻译至关重要.
- 进一步的研究和对障碍的战略导航可以释放这种治疗方法的全部潜力.
相关概念视频
Experimental RNAi
6.2K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.2K
RNA Interference
26.1K
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
26.1K
siRNA - Small Interfering RNAs
16.8K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
16.8K
Cancer Therapies
7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K
Rous Sarcoma Virus (RSV) and Cancer
5.1K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
5.1K
Microorganisms in Medicine and Therapeutics
49
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
49

